Data / Form D filings / Nevakar Inc.
Nevakar Inc.: Form D filings
Nevakar Inc., a pharmaceuticals company in Bridgewater, NJ, filed 2 Form D notices with the SEC between 2016 and 2023. The latest, on August 8, 2023, reports $4.6 million sold of a $12 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1019 US Highway 202-206, Building K, New Jersey Center of Excellence, Bridgewater, NJ, 08807
- Phone
- (908) 367-7400
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1677308
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 8, 2023 | New notice | $12,000,000 | $4,585,000 | $7,415,000 | 12 | Apr 24, 2023 | sec.gov |
| Jun 30, 2016 | New notice | Indefinite | $11,502,000 | 6 | Jun 9, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alex Sisson | Director | |
| Navneet Puri | Executive Officer, Director | |
| Ram Potti | Director | |
| George Zorich | Director | |
| Raul Trillo | Executive Officer, Director | |
| Ron Wooten | Director | |
| Sri Ramanathan | Executive Officer |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Aug 7, 2023 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Nevakar Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.